Date  |
|
| Mar 10, 2021 |
ReShape Lifesciences Announces Fourth Quarter and Full Year 2020 Financial Results |
| Mar 8, 2021 |
Reshape Lifesciences to Report Fourth Quarter and Full Year 2020 Financial and Operational Results on Wednesday, March 10, 2021 |
| Jan 20, 2021 |
ReShape Lifesciences Inc. to Merge With Obalon Therapeutics, Inc. to Expand Weight Loss Product Offering |
| Nov 12, 2020 |
ReShape Lifesciences Announces Third Quarter 2020 Financial and Operational Results |
| Nov 10, 2020 |
ReShape Lifesciences to Report Third Quarter 2020 Financial and Operational Results on Thursday, November 12, 2020 |
| Sep 15, 2020 |
First Twenty-Five Healthcare Professionals Enrolled in ReShapeCareTM, a Reimbursable, Evidence-Based Virtual Weight Management Program |
| Sep 10, 2020 |
ReShape Lifesciences™ Announces Positive Preclinical Results for Its Investigational Diabetes Bloc-Stim Neuromodulation Device |
| Aug 26, 2020 |
DAVTYAN MEDICAL WEIGHT LOSS & WELLNESS OF LOS ANGELES – AND COMMUNITY BARIATRICS HAMILTON OF INDIANAPOLIS – ENCOURAGE INDIVIDUALS WITH OBESITY TO REDUCE HEALTH RISKS ASSOCIATED WITH COVID-19 BY EXPLORING SURGICAL INTERVENTION AS AN OPTION |
| Aug 13, 2020 |
ReShape Lifesciences Announces Second Quarter 2020 Financial and Operational Results |
| Aug 11, 2020 |
ReShape Lifesciences to Report Second Quarter 2020 Financial and Operational Results on Thursday, August 13, 2020 |